Benzinga
Benzinga
Benzinga
miércoles, septiembre 23

Corteva Inc

CTVANYSE
Trade with Public
Trade with Public
$80.34
al cierre: Sep 23, 5:00 PM EST
$80.34
N/A
After hour: 4:34 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpciones

Corteva Financials

Corteva (CTVA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Corteva Sees FY2029 Sales $8.400B-$8.700B

Corteva (NYSE:CTVA) sees FY2029 sales of $8.400 billion-$8.700 billion.
Benzinga Newsdesk

PRO
Corteva Sees $300M Of Gross Productivity Benefits Across 2027-2029; Corteva Sees More Than $200M Of Net Cost Improvement Across 2027-2029, After Inflation And Tariff Offsets; Residual Inflation And Tariff Impacts Will Be Concentrated Mostly In 2027; Says Its Seed-Treatment Portfolio Is Now About $500M, Vs. About $400M Before Separation

- Investor Day
Benzinga Newsdesk

PRO
Corteva Raises FY2026 Adj EPS Guidance from $3.45-$3.70 to $3.60-$3.80 vs $3.75 Est

Corteva (NYSE:CTVA) raises FY2026 Adj EPS guidance from $3.45-$3.70 to $3.60-$3.80 vs $3.75 analyst estimate..
Benzinga Newsdesk

PRO
Corteva Q2 Adj. EPS $2.30 Beats $2.22 Estimate, Sales $6.379B Miss $6.582B Estimate

Benzinga Newsdesk

PRO
UPDATE: Corteva Q1 Adj. EPS $1.50 Beats $1.17 Estimate, Sales $4.905B Beat $4.643B Estimate

Corteva (NYSE:CTVA) reported quarterly earnings of $1.50 per share which beat the analyst consensus estimate of $1.17 by 28.21 percent. This is a 32.74 percent increase over earnings of $1.13 per share from the same period last year.
Benzinga Newsdesk

PRO
Corteva Affirms FY2026 Adj EPS Guidance of $3.45-$3.70 vs $3.65 Est

Corteva (NYSE:CTVA) affirms FY2026 Adj EPS guidance from $3.45-$3.70 to $3.45-$3.70 vs $3.65 analyst estimate..
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved